Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 31 citing Berk-Planken: Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes. (0.11 sec) 

Early vascular benefits of statin therapy


S Tsiara, M Elisaf, DP Mikhailidis - Current Medical Research and Opinion®, 2003 - informahealthcare.com
Large-scale trials established that statin administration in
hypercholesterolaemic individuals and patients with coronary heart disease (CHD)
significantly reduces the risk of vascular events and death. This benefit ...
Cited by 146 - Related articles - BL Direct - All 6 versions

A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients


E Gomez-Dominguez, JP Gisbert, JA Moreno- … - Alimentary Pharmacology and Therapeutics, 2006 - medscape.com
Currently, there are no proven effective therapies available for the treatment
of NAFLD and strategies have mainly led to treat or control underlying risk
factors. [1-4, 7, 11, 14] Promising pharmacological treatments have been ...
Cited by 53 - Related articles - BL Direct - All 11 versions

The-514 C-> T hepatic lipase promoter region polymorphism and plasma lipids: a meta- …

- endojournals.org
A Isaacs, FA Sayed-Tabatabaei, OT Njajou, J … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
Investigations of the –514 C T single nucleotide polymorphism (SNP) in the
hepatic lipase (HL) gene promoter region (LIPC) have yielded contradictory
results regarding its association with changes in plasma lipids. The ...
Cited by 42 - Related articles - BL Direct - All 5 versions

Therapeutic interventions targeted at the augmentation of reverse cholesterol transport

- mcrfmd.com [PDF] 
PP Toth, MH Davidson - Current Opinion in Cardiology, 2004 - journals.lww.com
Purpose of review Serum high-density lipoproteins (HDLs) and reverse cholesterol
transport (RCT) are important therapeutic targets in the management of
atherosclerotic disease. This review summarizes the pathway of RCT and the ...
Cited by 19 - Related articles - BL Direct - All 5 versions

Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated …

- eur.nl [PDF] 
GJ Botma, D van Deursen, D Vieira, M van … - Atherosclerosis, 2005 - Elsevier
Hepatic lipase (HL) not only plays an important role in plasma lipoprotein
transport, but may also affect intracellular lipid metabolism. We hypothesize
that HL expression is regulated as an integral part of intracellular lipid ...
Cited by 13 - Related articles - All 11 versions

[PDF] Transcription factor sterol regulatory element binding protein 2 regulates scavenger …


M Treguier, C Doucet, M Moreau, C Dachet, J … - Arteriosclerosis Thrombosis and Vascular Biology, 2004 - Am Heart Assoc
Objective—The human scavenger receptor class B type I (Cla-1) plays a key role
in cellular cholesterol movement in facilitating transport of cholesterol
between cells and lipoproteins. Indirect evidence has suggested that Cla-1 ...
Cited by 10 - Related articles - All 8 versions

The− 514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL- …


C Lahoz, R Peña, JM Mostaza, F Laguna, MF … - Atherosclerosis, 2005 - Elsevier
A number of studies have evaluated the effect of the −514C/T polymorphism of
the hepatic lipase (HL) gene on concentration and composition of the plasma
lipoproteins. However, the effect of this polymorphism on the response to ...
Cited by 10 - Related articles - All 4 versions

Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, …


A Cenarro, M Artieda, C Gonzalvo, E Merino- … - American Heart Journal, 2005 - Elsevier
The −514T allele frequency was higher in the ATOMIX group (0.297) than in the
control group (0.193) (P = .01). The −514T allele carriers in the control
group showed higher high-density lipoprotein cholesterol (HDL-C) ...
Cited by 7 - Related articles - All 6 versions

The Relationship of Lipoprotein Lipase Activity and LDL size Is Dependent on Glucose …

- Free from Publisher
G Bos, PG Scheffer, D Vieira, JM Dekker, G … - Diabetes care, 2004 - Am Diabetes Assoc
Small LDL size is common in patients with type 2 diabetes and is associated with
an increased risk of cardiovascular disease (1). LDL size is determined by
various constituents of lipoprotein metabolism, such as lipoprotein lipase ...
Cited by 6 - Related articles - BL Direct - All 8 versions

Interactions of dietary fat intake and the hepatic lipase-480C-> T polymorphism in …

- ajcn.org
G Bos, JM Dekker, EJM Feskens, MC Ocke, G … - American Journal of Clinical Nutrition, 2005 - Am Soc Nutrition
1 From the Institutes for Research in Extramural Medicine (GB, JMD, GN, CDAS,
LMB, and RJH) and Cardiovascular Research (CDAS and RJH), VU University Medical
Center, Amsterdam, Netherlands; the Center for Nutrition and Health, ...
Cited by 6 - Related articles - All 7 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google